Sentinel node biopsy in melanoma is not a good prognostic marker for individual patientsBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f651 (Published 06 February 2013) Cite this as: BMJ 2013;346:f651
- Jonathan L Rees, professor of dermatology1
- 1University of Edinburgh, Edinburgh EH3 9HA, UK
Torjesen deserves credit for her article on sentinel node biopsy (SNB) in melanoma,1 but it is sad that medicine needs a journalist to put its own house in order (excepting people like John Meirion Thomas). So much for evidence based medicine.
Other commentators have pointed out that the evidence that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial